Tag: exablate neuro

FDA approval of Exablate Neuro for the treatment of tremor-dominant Parkinson’s...

InSightec has announced that The Center for Devices and Radiological Health (CDRH) of the US Food and Drug Administration (FDA) has approved an expansion...

InSightec receives CE Mark for Exablate Neuro for Siemens Healthineers MRI...

New magnetic resonance imaging (MRI) compatibility holds potential to expand patient access around the world to incisionless brain surgery. Siemens Healthineers and InSightec have...

FDA approves pivotal study of Exablate Neuro for treatment of Parkinson’s...

INSIGHTEC has received approval from the US Food and Drug Administration (FDA) to initiate a pivotal study of the Exablate Neuro for treating dyskinesia...

First Alzheimer’s trial with focused ultrasound begins

Researchers at Sunnybrook Health Sciences Centre in Toronto, Canada have begun the world’s first clinical trial evaluating the feasibility and safety of opening the...

Siemens and InSightec sign strategic agreement to develop compatibility between some...

InSightec has signed a strategic agreement with Siemens Healthineers. The strategic collaboration will involve the development of compatibility between Exablate Neuro and Siemens 1.5T...

FDA approves first MRI-guided focused ultrasound device to treat essential tremor

The US Food and Drug Administration has approved the first focused ultrasound device to treat essential tremor in patients who have not responded to...

Health Canada approves Insightec’s Exablate Neuro system for the treatment of...

INSIGHTEC has announced that Health Canada has approved its Exablate Neuro system for the treatment of essential tremor. INSIGHTEC’s Exablate Neuro platform is transforming medicine...

Insightec broadcasts the first live Exablate Neuro brain treatment at ISTU...

At the 16th International Symposium on Therapeutic Ultrasound 2016 (ISTU) in Tel Aviv, Israel, INSIGHTEC hosted a first time live broadcast from the MRI room...

InSightec secures US$22 million and appoints Maurice R Ferré as chief...

InSightec has secured a US$22 million as part of its round D investment. This investment has been led by its current shareholders. In addition,...

Exablate Neuro platform approved by Korean Ministry of Food and Drug...

Elbit Imaging, a shareholder in InSightec, has announced that the company’s Exablate Neuro platform has been approved for the treatment of movement, pain and...

Insightec submits pre-market application for FDA approval of Exablate Neuro for...

Insightec has announced that it has submitted a pre-market approval application (PMA) to the US Food and Drug Administration (FDA) for its Exablate Neuro...

Insightec announces launch of Neurosurgery System on 1.5T MRI platform

Insightec has expanded its non-invasive neurosurgery system from 3T to 1.5T magnetic resonance imaging (MRI) systems. This launch expands the potential market for Insightec’s ExAblate...